Show results for
Refine by
Applications
- 3D bioprinting technology for breast disease
- 3D bioprinting technology for lung disease
- 3D bioprinting technology for brain disease
- 3D bioprinting technology for liver disease
- 3D bioprinting technology for skin disease
- 3D bioprinting technology for pancreas disease
- 3D bioprinting technology for prostate disease
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
Cells Combined With T Cells Equipment & Supplies In Moldova
466 equipment items found
by:Diasorin based inSALUGGIA, ITALY
Thanks to its team of dedicated scientists, DiaSorin has developed a new concept assay to maximize EARLY Lyme borreliosis detection through a unique combination of humoral and cell mediated immunity. The unique diagnostic value of B cells combined with T cells. LIAISON® LymeDetect® is an ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Concanamycin A is a specific inhibitor of vacuolar type H+-ATPase activity (V-ATPase) and is capable of inducing ...
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
Concanavalin A is a plant lectin that is a T cell mitogen. It induces apoptosis in human ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Thymopentin, also known as TP-5, is a synthetic derivative of thymopoietin, a thymic hormone, and has immunoregulatory properties. Thymopentin interacts with T cells, reduces endocrine and behavioral responses to experimental stress. It is also found to increase the number of cells undergoing apoptosis in irradiated cells and selectively bind to apoptotic ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
At TREOS we discovered that an individual’s HLA genotype is the main determinant of immune responses. This breakthrough led to the development of the PEPI Test (CE Marked) that predicts peptide-specific T cell responses of HLA genotyped individuals. Based on the PEPI Test we have been co-developing with each PolyPEPI™ product a Companion Diagnostic to predict likely responders and ...
Manufactured by:Terumo Blood and Cell Technologies, Inc. based inLakewood, COLORADO (USA)
Finia is an automated system that formulates and aliquots fluids, including cell suspensions, to prepare for cryopreservation. It consists of a device, a handheld barcode scanner, a monitor with a touch screen and functionally closed single-use disposable tubing ...
Manufactured by:InteGen LLC based inOrlando, FLORIDA (USA)
Multiplex ALL-1 probe is a multicolored chromosome mix which consists of six chromosomes labeled with a predominant color scheme. Telomeres and pericentromeric regions on each chromosome are labeled with spectrally distinct fluorochrome. The mix is viewed three chromosomes at a time using dual filters. This design detects all numerical and structural abnormalities related to B- and T-cell Acute ...
Manufactured by:Ardigen based inKraków, POLAND
Accelerate discovery and improve safety of TCR therapies using Artificial Intelligence. Following the unique opportunity for curing patients provided by the development of cell therapies (e.g. TCR discovery), Ardigen has set on the path to advance the field with its Artificial Intelligence platform. Many challenges stand in the way of successful therapy discovery and development. Let us know how ...
Manufactured by:Echelon Biosciences, Inc (EBI) based inSalt Lake City, UTAH (USA)
c ...
Manufactured by:TC BioPharm based inHolytown, UNITED KINGDOM
TCB007 is an unmodified allogeneic gamma delta T cell product, being used for the treatment of COVID-19. This product is at the CTA application stage and is expected to enter phase 1 trials in summer 2020. ...
Manufactured by:Genekam Biotechnology AG based inDuisburg, GERMANY
Genekam Human T-Cell Isolation kit: Magnetic separator, Isolation chemicals 5 ...
Manufactured by:Immudex ApS based inVirum, DENMARK
dCODE Dextramer technology enables the analysis of antigen-specific T cells by NGS or single-cell multi-omics. dCODE Dextramer adds a unique DNA barcode to the MHC Dextramer® reagent to detect antigen-specific T cells by NGS or single-cell multi-omics. High-avidity binding to T-cell receptors thanks to multiple MHC-peptide complexes. High-throughput screening with a unique barcode for each ...
Manufactured by:PeptaNova GmbH based inSandhausen, GERMANY
Phebestin is a synthetic inhibitor specifically targeting alanyl-aminopeptidase, also known as aminopeptidase N (APN). It plays a significant role in modulating the proliferation and function of human peripheral T cells. This compound, characterized by its (2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl-L-valyl-L-phenylalanine structure, is soluble in water, methanol, and DMSO, offering versatile ...
by:Genmab A/S based inCopenhagen V, DENMARK
DuoBody-CD40x4-1BB (GEN1042) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab’s DuoBody® technology. It is being co-developed under an agreement in which the companies share all costs and future profits for the product on a 50:50 basis. CD40 and 4-1BB were selected as targets to enhance both dendritic cells (DC) and antigen-dependent ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been ...
by:Vaxxinit based inDallas, TEXAS (USA)
Employs a “multitope” approach to neutralizing the SARS-CoV-2 virus, eliciting a well-balanced B and T-cell response against multiple viral epitopes. Phase 1 and Phase 2 trials of UB-612 have shown UB-612 to be well tolerated, with no significant safety findings to date, and inducing neutralizing titers against Omicron and other variants of concern. UB-612 is now in a Phase 3 ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Brentuximab vedotin (brand name: Adcetris) is a treatment for post-transplant consolidation, relapsed or refractory Hodgkin lymphoma (cancer of the lymphatic system distinguished by the presence of CD30-positive Reed-Sternberg cells), and systemic anaplastic large cell lymphoma (a type of aggressive T-cell ...
by:Vir Biotechnology, Inc. based inSan Francisco, CALIFORNIA (USA)
We are exploiting the unique immunology of human cytomegalovirus, or HCMV, a commonly occurring virus in humans, as a delivery vehicle – or vector – for vaccines to potentially treat and prevent infection by pathogens that are refractory to current vaccine technologies. HCMV is the most potent known inducer of T cell responses of any human virus and may induce potent and long-lasting ...
by:BlueSky Immunotherapies GmbH based inWien, AUSTRIA
The high level of interferon induced by the delNS vector activates immunological defence reactions against cancer. It also stimulates the production of antiviral ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
GSK-5498A is a selective CARC channel inhibitor (IC50: 1 μM). GSK-5498A inhibits mediators release from mast cells and pro-inflammatory cytokines release from T cells. GSK-5498A can be used in the research of inflammatory ...